FDA inspection
Apotex Pharmachem India Pvt Ltd.: FDA inspection ending Sep 2, 2022
FDA inspection 1180313 · No Action Indicated (NAI) · Bangalore
Key facts
| Inspection ID | 1180313 |
|---|---|
| Firm | Apotex Pharmachem India Pvt Ltd. |
| FEI number | 3005466325 |
| Address | Plot 1a Bommasandra Industrial Area 4th Phase, Jigani Link Road, Bommasandra Ind. Estate |
| City | Bangalore |
| Country | India |
| Fiscal year | 2022 |
| Inspection end date | Sep 2, 2022 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data